Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...

The S&P 500 declined by 0.5% on Friday, Jan. 31, as investors digested the White House’s proposed tariffs on Canada, China, and Mexico.

Pleas note: we will be discontinuing the Global Markets Report after 28 February. Australian shares are set to open lower, ...

The S&P 500 Index ($SPX) (SPY) today is up +0.67%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.04%, and the Nasdaq ...

Detailed price information for Deckers Outdoor Corp (DECK-N) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals (VRTX ... after suspending its quarterly dividend to conserve cash and strengthen its balance sheet.

Several gold stocks are in bases with earnings due. Two made new highs on Monday amid safe-haven demand on Trump tariff fears ...

If you’ve ever stared at Balatro’s deck selection screen, paralyzed by choice, wondering which deck will give you the upper hand, you’re not alone. Each deck is packed with unique perks ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...